Cantor Fitzgerald’s “Tracker Quants” laid out its forecasted changes for the upcoming Nasdaq 100 Index review. Nasdaq will implement its annual rebalance for its100 Index as of the close of December 20 and confirm the changes on December 13, Cantor tells investors in a research note. The firm sees Palantir (PLTR), MicroStrategy (MSTR) and Axon (AXON) being added to the Nasdaq 100 with Supermicro (SMCI), Moderna (MRNA) and Illumina (ILMN) being removed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLTR: